We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
45 hedge funds and large institutions have $134M invested in Verrica Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 6
67% more funds holding
Funds holding: 27 → 45 (+18)
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
0.01% more ownership
Funds ownership: 3.2% → 3.21% (+0.01%)
18% less capital invested
Capital invested by funds: $164M → $134M (-$30.1M)
Holders
45
Holders Change
+18
Holders Change %
+66.67%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
9
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.52M |
| 2 |
BlackRock
New York
|
+$4.36M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.54M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$1.16M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.06M |
